Ironwood Pharmaceuticals (IRWD) PT Lowered to $3 at Leerink Partners
Tweet
Share
E-mailGet Alerts IRWD Hot Sheet
Price: $4.08 -5.56%
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
11 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Leerink Partners analyst Faisal A. Khurshid lowered the price target on Ironwood Pharmaceuticals (NASDAQ: IRWD) to $3.00 (from $4.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
- Kingdee Int'l Software Group Co. (268:HK) (KGDEF) PT Lowered to HK$11.87 at Nomura/Instinet
- Maxell Ltd (6810:JP) PT Raised to JPY3,100 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
